Persantine

Active Ingredient(s): Dipyridamole
FDA Approved: * December 6, 1961
Pharm Company: * BOEHRINGER INGELHEIM
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Persantine Overview

Dipyridamole (trademarked as Persantine and others) is a medication that inhibits blood clot formation[3] when given chronically and causes blood vessel dilation when given at high doses over a short time. Contents 1 Mechanisms of action 2 Medical uses 2.1 Use in individuals with a history of stroke 2.2 Other uses 2.3 Drug Interactions 3 Overdose 4 See also 5 References Mechanisms of action Dipyridamole has two known effects, acting via different mechanisms of acti...

Read more Persantine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dipyridamole

Recent Persantine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dipyridamole
  • Injection: 5mg/ml
  • Tablet: 25mg, 50mg, 75mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Persantine: (3 results)

Sorted by National Drug Code
  • 0597-0017 Persantine 25 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0018 Persantine 50 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0019 Persantine 75 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.

Other drugs which contain Dipyridamole or a similar ingredient: (3 results)

Related Persantine Topics:

persantine for men
persantine...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA